This study aimed to investigate the effects of replacing added sugar with a sucralose-based non-nutritive sweetener (NNS) in daily beverages on cardiometabolic risk factors in adults with type 2 diabetes (T2D) in India. The study involved a randomized parallel arm trial, with participants aged 30-50 years, assigned to either the intervention group (replacing sugar with NNS) or the control group (no sugar replacement) for 12 weeks. Changes in anthropometric and biochemical markers were analyzed using established methods. The analysis included data from 115 participants who completed the study (42 in the control group and 73 in the intervention group).

  

The results showed significant reductions in waist circumference (p=0.02), lipid accumulation product (p=0.02), and visceral adiposity index (p=0.02) in the intervention group compared to the control group. Notably, when a subset of participants had their plasma sucralose levels measured, sucralose was undetectable, suggesting that it is not absorbed systemically.


Therefore, the study demonstrates that replacing added sugar with a sucralose-based non-nutritive sweetener leads to favorable changes in adiposity indices among adults with type 2 diabetes.

 

615-P. American Diabetes Association (ADA) 83rd Scientific Sessions, 23rd-26th June 2023, San Diego, CA.







Other Conference Highlights